Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
MBX Biosciences’ $187.7 Million IPO
River’s $40 Million Series B Funding Round
Goodwin advised River on the funding round. River closed its $40 million Series B led by Yamaha Motor Co., Ltd. The round also saw participation from existing...
Forma’s $40 Million Series B Funding Round
Goodwin advised Forma and Ribbit Capital on the deal. Forma announced its $40 million Series B funding round, led by Ribbit Capital. Forma (formerly Twic) is a...
Better Therapeutics’ $187 Million Merger Agreement with Mountain Crest Acquisition Corp II
Goodwin Procter LLP advised Better Therapeutics, Inc. on the deal. Better Therapeutics, Inc. announced its definitive merger agreement with Mountain Crest Acquisition Corp II (Nasdaq: MCAD;), a...